You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
回盛生物(300871.SZ):目前已有6款寵物藥品及14款寵物保健品上市,在研寵物藥品20個
格隆匯 05-04 15:24

格隆匯5月4日丨回盛生物(300871.SZ)於2023年4月27日進行電話及網絡會議,就“寵物板塊有哪些產品上市?公司在寵物板塊的研發、銷售方面的安排是怎樣的?”,公司表示,寵物類產品主要有驅蟲、消炎類藥品和保健品,目前已有6款寵物藥品及14款寵物保健品上市。公司寵物板塊已獲得馬波沙星片、頭孢泊肟酯片、非潑羅尼溶液3項新藥證書,在研寵物藥品20個,寵物類產品主要通過渠道經銷商、寵物醫院及線上銷售。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account